Leerink Partners Remains Sidelined on Amgen (AMGN) Following 2Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
Go back to Leerink Partners Remains Sidelined on Amgen (AMGN) Following 2Q
July 28, 2016 7:00 AM EDT
Baird analyst, Brian Skorney, reiterated his Neutral rating on shares of Amgen (NASDAQ: AMGN) after the company posted another solid quarter, with growth products continuing to deliver and the legacy portfolio retaining share. Many large caps have posted disappointing earnings but Amgen has been... More
July 28, 2016 6:46 AM EDT
BMO Capital analyst M. Ian Somaiya reiterated an Outperform rating and raised his price target on Amgen (NASDAQ: AMGN) to $190.00 (from $186.00) following top and bottom line beat in Q2.
Somaiya commented, "We are raising our price target on the AMGN shares to $190... More
July 27, 2016 4:02 PM EDT
Amgen (NASDAQ: AMGN) reported Q2 EPS of $2.84, $0.10 better than the analyst estimate of $2.74. Revenue for the quarter came in at $5.69 billion versus the consensus estimate of $5.58 billion.
GUIDANCE:
Amgen sees FY2016 EPS of $11.10-$11.40. Amgen sees FY2016 revenue of... More
July 26, 2016 5:21 PM EDT
Dan Loeb's Third Point LLC sold out of Amgen (NASDAQ: AMGN) in Q2, continued to hold its Allergan (NYSE: AGN) stake and continues to see meaningful upside in Baxter (NYSE:... More
July 26, 2016 2:56 PM EDT
The Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EDT
Durable Orders - Street sees (1.0%)Durable Orders: ex-transportation - Street sees 0.2%
Earnings:
Altria Group (NYSE: MO) - consensus EPS $0.80
Angie's List (Nasdaq: ANGI) - consensus loss $0.06
Anthem (NYSE: ANTM) - consensus EPS $3.23
Ballard Power (Nasdaq: BLDP) - consensus loss $0.04
Boeing (NYSE:... More
